Nicotine receptor partial agonists for smoking cessation

HIGHLIGHTS

• who: Nicotine receptor partial et al. from the cohort study published in , found no evidence of increased risk of suicide among, men and women who received varenicline and bupropion [2]Another important concern that has appeared in the literature is the cardiovascular risk when using varenicline. It is known that smokers have higher cardiovascular risk and that this is proportional to the number of cigarettes smoked., A meta-analysis, found increased cardiovascular risk associated with varenicline. However, another more recent meta-analysis did not find any increase in cardiovascular risk associated with varenicline, even in patients with . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.